SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-21-006634
Filing Date
2021-09-23
Accepted
2021-09-23 17:28:41
Documents
4
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_092321.htm 6-K 4700
2 PRESS RELEASE exh_991.htm EX-99.1 17584
3 EXHIBIT 99.2 exh_992.htm EX-99.2 11184
4 logo.jpg GRAPHIC 5743
  Complete submission text file 0001171843-21-006634.txt   42476
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 211273326
SIC: 2834 Pharmaceutical Preparations